IP Library Granted Patent US 10,988,789
Granted Patent B2
US 10,988,789 · App. 16/791,030 · Granted Apr 27, 2021

Glucosyltransferase enzymes for production of glucan polymers

Inventors: Mark S. Payne (Wilmington, DE); Yefim Brun (Wilmington, DE); Hongxian He (Wilmington, DE); Thomas Scholz (Bear, DE)
Assignee: NUTRITION & BIOSCIENCES USA 4, INC.
C12P19/18C08B37/0009C12N9/1048C12N9/1051C12P19/04C12Y204/01005C12Y204/01267Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,988,789
App. No.
16/791,030
Granted
Apr 27, 2021
Kind
B2
Abstract

Reaction solutions are disclosed herein comprising water, sucrose and a glucosyltransferase enzyme that synthesizes poly alpha-1,3-glucan. The glucosyltransferase enzyme can synthesize insoluble glucan polymer having at least 50% alpha-1,3 glycosidic linkages and a number average degree of polymerization of at least 100. Further disclosed are methods of using such glucosyltransferase enzymes to produce insoluble poly alpha-1,3-glucan.

Claims (22)

1. A composition comprising (i) an insoluble poly alpha-1,3-glucan having at least 90% alpha-1,3 glycosidic linkages, and (ii) a genetically engineered cell that expresses an isolated glucosyltransferase enzyme comprising an amino acid sequence that is at least 90% identical to SEQ ID NO:4.

2. The composition of claim 1 , wherein said insoluble poly alpha-1,3-glucan has a number average degree of polymerization of at least 100.

3. The composition of claim 1 , wherein said insoluble poly alpha-1,3-glucan has at least 95% alpha-1,3 glycosidic linkages.

4. The composition of claim 1 , wherein said insoluble poly alpha-1,3-glucan has at least 97% alpha-1,3 glycosidic linkages.

5. The composition of claim 1 , wherein said insoluble poly alpha-1,3-glucan has at least 99% alpha-1,3 glycosidic linkages.

6. The composition of claim 1 , wherein said insoluble poly alpha-1,3-glucan has about 100% alpha-1,3 glycosidic linkages.

7. The composition of claim 1 , wherein said glucosyltransferase enzyme comprises an amino acid sequence that is at least 93% identical to SEQ ID NO:4.

8. The composition of claim 1 , wherein said glucosyltransferase enzyme comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:4.

9. The composition of claim 1 , wherein said glucosyltransferase enzyme comprises an amino acid sequence that is at least 97% identical to SEQ ID NO:4.

10. The composition of claim 1 , wherein said glucosyltransferase enzyme comprises an amino acid sequence that is at least 98% identical to SEQ ID NO:4.

11. The composition of claim 1 , wherein said glucosyltransferase enzyme comprises an amino acid sequence that is at least 99% identical to SEQ ID NO:4.

12. The composition of claim 1 , wherein a heterologous amino acid sequence of 1-300 residues is at the N-terminus and/or C-terminus of said glucosyltransferase enzyme.

13. The composition of claim 1 , wherein the composition further comprises fructose.

14. The composition of claim 13 , wherein the composition further comprises glucose, sucrose, or leucrose.

15. The composition of claim 13 , wherein the composition further comprises glucose, sucrose and leucrose.

16. The composition of claim 1 , wherein the genetically engineered cell is a bacteria cell.

17. The composition of claim 16 , wherein the bacteria cell is an E. coli cell.

18. The composition of claim 16 , wherein the bacteria cell is a Bacillus species cell.

19. The composition of claim 1 , wherein the genetically engineered cell is a yeast cell.

20. The composition of claim 19 , wherein the yeast cell is a Saccharomyces species cell.

21. The composition of claim 19 , wherein the yeast cell is a Pichia species cell.

22. The composition of claim 1 , wherein composition further comprises water.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2020
From: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
To: NUTRITION & BIOSCIENCES USA 4, INC.
Reel/Frame 055028/0496 →
Continuity (11)
Continuation 16401166 · May 2, 2019
Continuation 16163701 · Oct 18, 2018
Continuation 15080691 · Mar 25, 2016
Division 14490869 · Sep 19, 2014
Division 14036049 · Sep 25, 2013
Provisional Application 61705177 · Sep 25, 2013
Provisional Application 61705178 · Sep 25, 2012
Provisional Application 61705179 · Sep 25, 2012
Provisional Application 61705180 · Sep 25, 2012
Provisional Application 61705181 · Sep 25, 2012
Related Publication 20200325513A1 · Oct 15, 2020